MiR-203 also inhibits prostatic cancer metastatic potential by suppressing RAP1A (ras-related protein 1A) expression [15] and suppresses ZNF217 (zinc finger protein 217) oncogenic activity in colorectal cancer [16]. Here, ZNF217 is linked to prostate carcinoma.